Peer Review | Comparing Findings From a Friends of Cancer Research Exploratory Analysis of Real-World End Points With the Cancer Analysis System in England
Randomized controlled trials (RCTs) are the gold standard for assessing safety and efficacy of drugs; however, RCTs have limitations such as controlled settings, selective patient populations, and short-term study outcomes that might not be generalizable to heterogenous real-world populations and settings.1–3 There is a need to understand the effectiveness of medical interventions in representative real-world populations…